--- title: "Cardiovascular & Respiratory Medicines" ocid: "ocds-r6ebe6-0000577439" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000577439" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000577439.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000577439.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")" published: "2019-07-16" --- # Cardiovascular & Respiratory Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") Current stage: Award OCID: ocds-r6ebe6-0000577439 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000577439) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000577439.json) ## Summary The procurement process, initiated by The Common Services Agency (NHS National Services Scotland), involves a framework agreement titled "Cardiovascular & Respiratory Medicines". This procurement falls under the health sector and is located in Edinburgh, Scotland. Currently, the procurement is in the Award stage, with all relevant contracts having been signed on 1 July 2019. The procurement method employed is an open procedure, and the tender was officially closed for submissions on 30 April 2019. This tender offers substantial opportunities for businesses specialising in pharmaceutical supplies, particularly those providing cardiovascular and respiratory medicines. Companies with the capability to supply a diverse range of healthcare products, such as those producing modified release capsules, inhalers, and injectable medications, will find this framework beneficial. Given the multi-supplier unranked approach, a maximum of six suppliers will be awarded for each lot, creating a competitive landscape wherein both large and small firms can participate effectively. ## Notice This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ### Lot Information Epoprostenol powder and solvent (pH12) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Epinephrine (Adrenaline) Auto Injector Devices Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority has not awarded this Lot. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Urokinase Injections Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire Isosorbide Mononitrate Modified Release Capsules and Tablets Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Diltiazem Hydrochloride Modified Release Capsules and Tablets Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Verapamil Hydrochloride Modified Release Capsules and Tablets Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Nifedipine Modified Release Capsules and Tablets Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Theophylline Modified Release Capsules and Tablets Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has not awarded this Lot. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Branded and Branded Generic Inhalers Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. All Other Cardiovascular & Respiratory Medicines Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was tendered as an individual Lot and awarded to a single framework participant. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire Bosentan Tablets Supply of Bosentan Tablets to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Epoprostenol powder and solvent (pH10.5) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Fondaparinux Sodium Pre-filled Syringes Supply of Fondaparinux Sodium Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority has not awarded this Lot. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. Epinephrine (Adrenaline) Injections Supply of Epinephrine (Adrenaline) Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360816 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 16 Jul 2019 | | Submission deadline | 30 Apr 2019 | | Future notice date | Not specified | | Award date | 1 Jul 2019 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £32,858,043 | | Lots value | £32,571,777 | | Awards value | Not specified | | Contracts value | £15,912,988 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Unsuccessful | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 38 | | Supplier names | ACTAVIS; AGUETTANT; ASPIRE PHARMA; AVENTIS PHARMA LTD TRADING AS SANOFI; BAXTER HEALTHCARE; BOWMED IBISQUS; BROWN AND BURK; CHIESI; CIPLA (EU; CONSILIENT HEALTH; CRESCENT PHARMA; DR REDDY'S LABORATORIES (UK; ENNOGEN HEALTHCARE; FOCUS PHARMACEUTICALS; GALEN; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMACEUTICALS; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; MARTINDALE PHARMA; MERCK SHARP & DOHME; MERCURY PHARMA GROUP; MORNINGSIDE PHARMACEUTICALS; MYLAN UK HEALTHCARE; PANPHARMA; PFIZER; RANBAXY; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; SYNCHRONY PHARMA; SYNER-MED (PP; SYRI LIMITED T/A THAME LABORATORIES; TEVA; TORRENT PHARMA (UK; TYPHARM; WOCKHARDT | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 16 Jul 2019 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360816 - 22 Mar 2019 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR349301 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR349301 Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360816 Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - http://www.publiccontractsscotland.gov.uk/info/InfoCentre - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000577439 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000577439. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000577439.json.